AbbVie
ABBV
£132.83
Share price
1.41%
Change (1 day)
-2.29%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
P/S ratio for AbbVie (ABBV)
P/S ratio as of April 2025 (TTM): 5.54
According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 92.7. At the end of 2024 the company had a P/S ratio of 5.58.
P/S ratio history for AbbVie from 2012 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 5.58 | 10.86% |
| 2023 | 5.04 | 2.32% |
| 2022 | 4.92 | 15.58% |
| 2021 | 4.26 | 3.14% |
| 2020 | 4.13 | 4.92% |
| 2019 | 3.94 | -5.43% |
| 2018 | 4.16 | -23.93% |
| 2017 | 5.47 | 37.85% |
| 2016 | 3.97 | -4.86% |
| 2015 | 4.17 | -20.04% |
| 2014 | 5.22 | 16.95% |
| 2013 | 4.46 | 51.93% |
| 2012 | 2.94 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 2.00 | -63.83% | 🇺🇸 USA |
 | 2.04 | -63.20% | 🇺🇸 USA |
 | 16.5 | 197.59% | 🇺🇸 USA |
 | 4.49 | -19.00% | 🇺🇸 USA |
 | 4.60 | -17.01% | 🇺🇸 USA |
 | 1.79 | -67.66% | 🇺🇸 USA |
 | 1.86 | -66.35% | 🇬🇧 UK |
 | 3.95 | -28.76% | 🇬🇧 UK |
 | 4.36 | -21.35% | 🇺🇸 USA |